Skip to main content

Table 5 The two-years Hazard ratio for the need of mitral valve surgery, Heart failure hospitalization events, and composite endpoints a among the study population

From: Clinical and echocardiographic trends in percutaneous balloon mitral valvuloplasty

Characteristics [N] HR for MVR surgery
[CI %95%]
HR for HF hospitalization
[CI 95]
HR for Composite Endpoints a
[CI %95%]
P-value
Wilkins Score > 8 3.648 [2.34–5.68] 2.724 [1.76–4.21] 2.330 [1.57–3.45] <.0001
Post-Procedural MR ≥ 2 4.03 [2.05–7.92] 9.07 [4.73–17.38] 3.127 [1.63–5.96] <.0001
Post-Procedural MVA < 1.5 2.44 [1.63–3.64] 10.06 [6.89–14.51] 2.33 [1.62–3.35] <.0001
  1. HR Hazard ratio, HF heart failure
  2. a 2-years composite endpoints for Heart Failure hospitalization, Mitral Valve Surgery, and worsening functional capacity (assessed by the New York Heart Association classification)